By otakuyassine3@gmail.com 
R Squared Ltd acquired a new position in shares of Colgate-Palmolive (NYSE:CL – Free Report) in the fourth quarter, HoldingsChannel reports. The fund acquired 1,810 shares of the company’s stock, valued at approximately $165,000.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Algert Global LLC raised its holdings in Colgate-Palmolive by 14.4% in the second quarter. Algert Global LLC now owns 5,131 shares of the company’s stock worth $498,000 after purchasing an additional 647 shares during the period. NewEdge Advisors LLC raised its stake in Colgate-Palmolive by 11.7% during the 2nd quarter. NewEdge Advisors LLC now owns 51,375 shares of the company’s stock worth $4,985,000 after buying an additional 5,363 shares during the period. B. Riley Wealth Advisors Inc. lifted its holdings in Colgate-Palmolive by 7.3% during the second quarter. B. Riley Wealth Advisors Inc. now owns 17,851 shares of the company’s stock worth $1,732,000 after acquiring an additional 1,212 shares in the last quarter. SPC Financial Inc. acquired a new position in Colgate-Palmolive in the second quarter valued at about $227,000. Finally, 3Chopt Investment Partners LLC bought a new stake in shares of Colgate-Palmolive in the second quarter worth about $400,000. Institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Trading Down 0.2 %
Shares of NYSE:CL opened at $89.65 on Thursday. Colgate-Palmolive has a 52-week low of $82.68 and a 52-week high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The company has a market capitalization of $73.24 billion, a P/E ratio of 25.69, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44. The company has a 50-day simple moving average of $91.67 and a 200 day simple moving average of $97.34.
Colgate-Palmolive Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.23%. Colgate-Palmolive’s payout ratio is 57.31%.
Wall Street Analyst Weigh In
Several equities analysts have recently weighed in on CL shares. UBS Group cut their price objective on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a report on Thursday, January 16th. Stifel Nicolaus cut their price target on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research note on Friday, January 17th. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Wells Fargo & Company cut their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. lowered their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $102.00.
View Our Latest Stock Analysis on Colgate-Palmolive
Insider Transactions at Colgate-Palmolive
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.34% of the stock is currently owned by corporate insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Colgate-Palmolive and related companies with MarketBeat.com’s FREE daily email newsletter.